ASIA PACIFIC DNA SEQUENCING MARKET FORECAST 2019-2027

ASIA PACIFIC DNA SEQUENCING MARKET FORECAST 2019-2027

  • January 2019 •
  • 92 pages •
  • Report ID: 4595251 •
  • Format: PDF
KEY FINDINGS
The Asia-Pacific DNA sequencing market is expected to exhibit the fastest CAGR rise in the global market.By the end of the forecast period of 2019-2027, the market is predicted to account for $XX million, a significant increase from its 2018 value of $XX million.

This growth can be attributed to a 17.63% CAGR. China and India represent growth of the Asia Pacific market for DNA sequencing services and products due to the increased food and environmental testing and overseas migration of sequencing services.

MARKET INSIGHTS
In the Asia Pacific region, India and China are the emerging countries, with the highest number of the geriatric population.These countries also have experienced a significant increase in lifestyle diseases and other major chronic conditions.

The Japanese market is expected to register the highest revenue reaped in this region.Japan is also one of the largest importers of GMO foods.

The country benefits from a well-established R&D infrastructure, advanced clinical testing industry, and strong national interest in cancer diagnostics. Though the Asia-Pacific market is expected to showcase the highest growth during 2019-2027 tenure, the market growth could be restrained by the lack of skilled professionals and accuracy and standardization issues in diagnostic testing.

COMPETITIVE INSIGHTS
Some of the well-known top players trading in this market are F. Hoffmann-La Roche Ltd., Adaptive Biotechnologies, Inc., Pacific Biosciences, Ubiquity Genomics, Inc., Appistry Inc., Thermo Fisher Scientific, Inc., Asuragen, Inc., BGI, Illumina, Roche Diagnostics, Spiral Genetics, Inc., Wafergen Bio-Systems, Inc. (merged with Takara Bio), Agilent Technologies, Inc., Abbott Laboratories, ZS Genetics, Inc. and Cell Microsystems, Inc.

Companies mentioned
1. ABBOTT LABORATORIES.
2. ADAPTIVE BIOTECHNOLOGIES, INC.
3. AGILENT TECHNOLOGIES, INC.
4. APPISTRY, INC.
5. ASURAGEN, INC.
6. BGI
7. CELL MICROSYSTEMS, INC.
8. F. HOFFMANN-LA ROCHE LTD.
9. ILLUMINA
10. PACIFIC BIOSCIENCES
11. ROCHE DIAGNOSTICS
12. SPIRAL GENETICS, INC.
13. THERMO FISHER SCIENTIFIC, INC.
14. UBIQUITY GENOMICS, INC.
15. WAFERGEN BIO-SYSTEMS, INC. (MERGED WITH TAKARA BIO)
16. ZS GENETICS, INC.